Literature DB >> 10838094

Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins.

K M Jernigan1, R Blumenthal, A Puri.   

Abstract

We examined fusion mediated by the human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) envelope glycoproteins under various experimental conditions. Incubation of HeLa cells expressing HIV-2(ROD) and HIV-2(SBL/ISY) envelope glycoproteins with HeLa-CD4 target cells resulted in fusion at temperatures >/=25 degrees C whereas fusion with cells expressing HIV-1(Lai) occurred only at >/=31 degrees C. HIV-2 envelope glycoprotein-mediated fusion proceeded in the absence of Ca(2+) in the culture medium, whereas HIV-1 fusion required Ca(2+) ions for fusion. In contrast to HIV-2 envelope glycoprotein fusion, incubations in the presence of the 0.5 microM cytochalasin B completely inhibited HIV-1 envelope glycoprotein-mediated fusion. Our results suggest that in contrast to HIV-2, HIV-1 fusion is dependent on dynamic processes in the target membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838094     DOI: 10.1016/s0014-5793(00)01600-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.

Authors:  Catherine M Finnegan; Werner Berg; George K Lewis; Anthony L DeVico
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection.

Authors:  Agustín Valenzuela-Fernández; Susana Alvarez; Mónica Gordon-Alonso; Marta Barrero; Angeles Ursa; J Román Cabrero; Gerónimo Fernández; Salvador Naranjo-Suárez; Maria Yáñez-Mo; Juan M Serrador; M Angeles Muñoz-Fernández; Francisco Sánchez-Madrid
Journal:  Mol Biol Cell       Date:  2005-09-07       Impact factor: 4.138

3.  Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.

Authors:  C M Finnegan; W Berg; G K Lewis; A L DeVico
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion.

Authors:  Samvel R Mkrtchyan; Ruben M Markosyan; Michael T Eadon; John P Moore; Gregory B Melikyan; Fredric S Cohen
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.

Authors:  S E Pontow; N Vander Heyden; S Wei; L Ratner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.

Authors:  Satinder S Rawat; Stephen A Gallo; Julie Eaton; Thomas D Martin; Sherimay Ablan; Vineet N KewalRamani; Ji Ming Wang; Robert Blumenthal; Anu Puri
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.

Authors:  Hana Golding; Marina Zaitseva; Eve de Rosny; Lisa R King; Jody Manischewitz; Igor Sidorov; Miroslaw K Gorny; Susan Zolla-Pazner; Dimiter S Dimitrov; Carol D Weiss
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Influence of calcium on lipid mixing mediated by influenza hemagglutinin.

Authors:  Mikhail A Zhukovsky; Ingrid Markovic; Austin L Bailey
Journal:  Arch Biochem Biophys       Date:  2007-05-25       Impact factor: 4.013

9.  Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.

Authors:  Stephen A Gallo; Jacqueline D Reeves; Himanshu Garg; Brian Foley; Robert W Doms; Robert Blumenthal
Journal:  Retrovirology       Date:  2006-12-04       Impact factor: 4.602

Review 10.  Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm.

Authors:  Gregory B Melikyan
Journal:  Retrovirology       Date:  2008-12-10       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.